ALEXANDRIA, Va., April 21 -- United States Patent no. 12,606,527, issued on April 21, was assigned to Helsinn Healthcare SA (Lugano, Switzerland).
"Crystalline forms of an NK-1 antagonist" was invented by Christian Bacilieri (Breganzona, Switzerland) and Gionata Frasca (Minusio, Switzerland).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention is related to crystalline forms of 2-(3,5-bis(trifluoromethyl)phenyl)-N,2-dimethyl-N-(6-(4-methylpiperazin-1-yl)-4-(o-tolyl)pyridin-3-yl)propanamide which is an NK-1 antagonist useful in the treatment of induced vomiting and other disorders."
The patent was filed on July 14, 2024, under Application No. 18/772,244.
*For further information, including im...